In scramble to stop virus, testing raises tough questions
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Thursday
June 30, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
THURSDAY, JUNE 30, 2022
In scramble to stop virus, testing raises tough questions

Coronavirus chronicle

Reuters
28 February, 2020, 12:20 pm
Last modified: 28 February, 2020, 12:23 pm

Related News

  • Elton John has COVID, postpones U.S. tour dates
  • Tushar Khan in ICU
  • Covid-19: Bangladesh rolls out booster dose in Dhaka
  • Omicron cases doubling in 1.5 to 3 days in areas with local spread - WHO
  • Health costs during pandemic pushed over half a billion people into poverty

In scramble to stop virus, testing raises tough questions

Reuters
28 February, 2020, 12:20 pm
Last modified: 28 February, 2020, 12:23 pm
This undated photo provided by U.S. Centers for Disease Control and Prevention shows CDC’s laboratory test kit for the new coronavirus. (CDC via AP)
This undated photo provided by U.S. Centers for Disease Control and Prevention shows CDC’s laboratory test kit for the new coronavirus. (CDC via AP)

Health officials confronted tough questions and doubts Thursday about testing to intercept the fast-spreading virus, with scrutiny focused on a four-day delay in screening an infected California woman despite her doctors' early calls to do so.

The questions are global: not just who, when and how to test for the illness, but how to make sure that working test kits get out to the labs that need them. All those issues apparently came in to play in the treatment of the woman in northern California, a case officials say may be the first community-spread instance of the disease in the US

"This was a clear gap in our preparedness, and the virus went right through the gap," said Dr. Ali Khan, dean of the University of Nebraska College of Public Health.

In the wake of the latest California case, US health officials on Thursday expanded their criteria for who should get tested, and took steps to increase testing.

The debate over testing has taken on added urgency as the number of cases worldwide climbed past 82,000, including 2,800 reported deaths. The rapid spread pushed officials in Saudi Arabia to cut travel to Islam's holiest sites, triggered tougher penalties in South Korea for people who break quarantines and ratcheted up pressure on investors as US stock markets extended their week-long plunge. The Dow Jones Industrial Average sank nearly 1,200 points Thursday, its worst one-day drop since 2011.

With the illness rippling across 47 nations in every continent but Antarctica, public health officials emphasized the need for rapid intervention.

"Aggressive early measures can prevent transmission before the virus gets a foothold," World Health Organization chief Tedros Adhanom Ghebreyesus said. He cited a study in China of more than 320,000 test samples that enabled health officials to zero in on the 0.14 percent that screened positive for COVID-19, the disease caused by the virus.

But catching the disease early will require countries to invest in rapid diagnostics, said Dr. Gagandeep Kang, a microbiologist who heads the Translational Health Science And Technology Institute in India.

Test kits used by the World Health Organization cost less than $5 each, said Michael Ryan, the group's emergencies programs director. But that figure does not include the expense of medical staff and validation screening, and making such investments effective goes well beyond the expense involved.

"As we can see from the new sparks on Italy, Iran, Korea, is that early identification of cases is crucial. There, the first persons with infection were missed," said Marion Koopmans of the Erasmus Medical Center in the Netherlands.

Doctors at the University of California Davis Medical Center were mindful of the need for early identification on Feb. 19 when the hospital admitted a female patient on a ventilator who showed symptoms of a viral infection. They asked she be tested for the new coronavirus, according to an email hospital officials sent to their employees, but a test was not administered because she did not fit federal test criteria. The test was not done until four days later, on Feb. 23, and the results did not come back until Wednesday, a full week after she was admitted, the hospital said.

The federal agency in charge of testing, the US Centers for Disease Control and Prevention, took issue with that account late Thursday. The agency said it was still investigating, but that a preliminary review showed it had not been informed of the case until Feb. 23, when it requested specimens for testing. It said criteria in place at the time could have allowed the woman to be tested earlier.

The case highlights the fact that most testing in US up to now has been limited to those who, in addition to showing symptoms, have a history of travel to countries affected by the disease or contact with those who have done so, said Lauren Sauer, director of operations at Johns Hopkins University's Office of Critical Event Preparedness and Response.

"In the US, people are sticking pretty closely to that definition," Sauer said. But the increasing cases on other continents "are demonstrating we need to do a better job than just where the outbreak originated."

On Thursday, the CDC updated its testing criteria on its website — a move that had been in the works for days, according to a federal official familiar with the change.

The CDC will continue to advise testing people who have traveled to certain outbreak areas and have fever and certain other symptoms. But now testing is also appropriate if such symptoms exist and flu and other respiratory illnesses have been ruled out and no source of exposure has been identified.

As part of that, CDC has expanded the list of countries that are red flags for testing to include not only China but Iran, Italy, South Korea and Japan.

Last month, the CDC said it had developed a test kit that could be sent to state and big city public health labs, so they could broaden testing to more people. Early this month, the agency got authorization to begin distribution of the kit to government public health labs in the 50 states and some cities and counties.

But most of the kits proved to be faulty, providing inconclusive results to test samples that should have tested positive. The problem was blamed on one of three reagents used in the testing. CDC said it was trying to manufacture new reagents, but gave no firm timetable for when that would occur.

Only about a half dozen state and local public health labs had fully functional kits as of early this week.

As weeks passed, the problem became more and more frustrating, said Scott Becker, the chief executive of the Association of Public Health Laboratories.

On Monday, Becker's organization sent a letter to the US Food and Drug Administration, basically asking permission for state labs to develop their own tests. On Wednesday, FDA officials responded that labs would be allowed to rely on the two other reagents, meaning that as many as 40 state and local labs could be up and running with their tests in the next few days, Becker said.

The California case, and remarks by Italian officials that they were rethinking how to classify people who test positive for the illness but show no symptoms, highlighted the questions that surround large-scale screening for the disease.

The test being used by US health officials takes just four to six hours to perform once it's in a lab. But up to now, those tests have been sent to federal testing centers, often significantly extending the time to get results.

"Testing protocols have been a point of frustration," California Gov. Gavin Newsom said Thursday. He said federal officials had assured their state counterparts that capacity to test will be growing "exponentially" in the next few days, but he wasn't more specific.

Federal official likely limited testing early on because of concerns about a deluge of false positives, which could panic communities and become counterproductive, said Khan, a former top disease investigator for the CDC.

But he suggested that a tiered testing system might be the answer, in which a positive test would have to be verified by another lab before a case is diagnosed and counted.

The challenge is complicated by a slowness to distribute test kits.

Newsom said Thursday the state had just 200 testing kits on hand and "that's simply inadequate." He said he spoke to CDC officials and they assured him they were working to make testing more broadly available in California.

In Italy, where an outbreak has depressed tourism and fueled panic, officials said Thursday they would change their reporting and testing practices in ways that could lower the country's reported caseload.

Italian authorities plan from now on to distinguish between people who test positive for the virus and patients showing symptoms, since the majority of the people in Italy with confirmed infections aren't actually sick. They said they would follow urging by the WHO and hold off on certifying cases screened only at a regional level, until they can be confirmed by national officials.

"The cases that emerge from the regions are still considered suspect and unconfirmed," said Walter Ricciardi, a WHO adviser to the Italian government.

But US experts said the crisis requires more rapid testing, and a willingness by officials to revise their criteria. Sauer pointed to a case in Canada, where officials zeroed in on a traveler from Iran with COVID-19 soon after that country announced its first cases.

"Let our really smart doctors do what they do really well," Khan said. "If they are really suspicious that a pneumonia or influenza-like illness does not quite look like an influenza-like illness, allow them to test!"

Top News

corona virus / testing

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Bangladesh Bank hikes policy rate to tighten money flow
    Bangladesh Bank hikes policy rate to tighten money flow
  • Seven more jute mills going private
    Seven more jute mills going private
  • Photo: TBS
    Jitu attacked teacher Utpal for stopping him from pursuing girl: RAB

MOST VIEWED

  • Test tubes are seen in front of displayed Pfizer and Biontech logos in this illustration taken, May 21, 2021. Reuters: llustration
    BioNTech, Pfizer to start testing universal vaccine for coronaviruses
  • A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
    S Korea approves first domestically developed Covid vaccine
  • Photo: Collected
    US medical experts call for Omicron-specific Covid boosters
  • David E Adler. Sketch: TBS
    Who managed Covid-19 best, and why?
  • People line up at a nucleic acid testing station, following the coronavirus disease (COVID-19) outbreak, in Beijing, China, June 16, 2022. REUTERS/Thomas Peter/File Photo
    China slashes Covid quarantine time for international travellers
  • Covid-19 deaths were reported from Gorakhpur, Jalaun, Bulandshahr, Kannauj, Sonbhadra, Gonda, Bhadohi, Basti, Kushinagar and Mau (HT Photo)
    India sees 45% jump in a day with 17,073 new Covid cases

Related News

  • Elton John has COVID, postpones U.S. tour dates
  • Tushar Khan in ICU
  • Covid-19: Bangladesh rolls out booster dose in Dhaka
  • Omicron cases doubling in 1.5 to 3 days in areas with local spread - WHO
  • Health costs during pandemic pushed over half a billion people into poverty

Features

Bangladesh ranks among the top ten countries whose citizens have sought asylum in Cyprus. Photo: Arafatul Islam/DW

How Bangladeshi migrants end up in Cyprus

2h | Panorama
Dr M Mushtuq Husain. Sketch: TBS

'We did not face an extreme crisis with Omicron. But this wave is spreading faster'

5h | Panorama
Luxury Houseboat owners  distributed food, provided medical assistance, and shelter to the flood victims, till the flood waters receded Photo: Masum Billah

The first responders: How luxury houseboats became rescue centres for flood victims

6h | Panorama
Mahathir accused financial titans of seeking to reverse decades of economic development that propelled tens of millions into the middle class. Photo: Bloomberg

George Soros, Mahathir and the legacy of 1997

1d | Panorama

More Videos from TBS

Khaled Masud  Pilot starts his second innings in restaurant business

Khaled Masud Pilot starts his second innings in restaurant business

6h | Videos
Severodonetsk now under Russian control

Severodonetsk now under Russian control

18h | Videos
South African boy drove ambition, says Elon's father

South African boy drove ambition, says Elon's father

18h | Videos
Why Dollar crisis will last long?

Why Dollar crisis will last long?

18h | Videos

Most Read

1
Padma Bridge from satellite. Photo: Screengrab
Bangladesh

Padma Bridge from satellite 

2
Meet the man behind 'Azke amar mon balo nei'
Splash

Meet the man behind 'Azke amar mon balo nei'

3
Photo: TBS
Bangladesh

Motorcycles banned on Padma Bridge 

4
Photo: Courtesy
Corporates

Gree AC being used in all parts of Padma Bridge project

5
Photo: Collected
Economy

Tech startup ShopUp bags $65m in Series B4 funding

6
World Bank to give Bangladesh $18b IDA loans in next five years
Economy

World Bank to give Bangladesh $18b IDA loans in next five years

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab
BENEATH THE SURFACE
Workers unload sacks of paddy at the BOC Ghat paddy market on the bank of the Meghna River in Brahmanbaria’s Ashuganj, the largest paddy market in the eastern part of the country. This century-old market sells paddies worth Tk5-6 crore a day during the peak season. PHOTO: RAJIB DHAR

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net